HighTower Advisors’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $116K | Sell |
118,339
-6,547
| -5% | -$6.45K | ﹤0.01% | 3408 |
|
|
2025
Q1 | $180K | Buy |
124,886
+20,625
| +20% | +$29.7K | ﹤0.01% | 3203 |
|
|
2024
Q4 | $229K | Sell |
104,261
-1,310
| -1% | -$2.88K | ﹤0.01% | 3074 |
|
|
2024
Q3 | $176K | Sell |
105,571
-131,214
| -55% | -$219K | ﹤0.01% | 3163 |
|
|
2024
Q2 | $514K | Buy |
236,785
+49,619
| +27% | +$108K | ﹤0.01% | 2289 |
|
|
2024
Q1 | $496K | Buy |
187,166
+137,597
| +278% | +$365K | ﹤0.01% | 2286 |
|
|
2023
Q4 | $149K | Buy |
49,569
+25,211
| +104% | +$75.8K | ﹤0.01% | 3067 |
|
|
2023
Q3 | $23K | Buy |
24,358
+765
| +3% | +$722 | ﹤0.01% | 3243 |
|
|
2023
Q2 | $32K | Buy |
+23,593
| New | +$32K | ﹤0.01% | 3158 |
|
|
2020
Q4 | – | Sell |
-32,753
| Closed | -$1.22M | – | 2446 |
|
|
2020
Q3 | $1.22M | Buy |
32,753
+12,185
| +59% | +$453K | 0.01% | 1111 |
|
|
2020
Q2 | $1.06M | Sell |
20,568
-25
| -0.1% | -$1.29K | 0.01% | 1089 |
|
|
2020
Q1 | $650K | Sell |
20,593
-1,275
| -6% | -$40.2K | ﹤0.01% | 1199 |
|
|
2019
Q4 | $1.3M | Buy |
21,868
+1,519
| +7% | +$90.5K | 0.01% | 1018 |
|
|
2019
Q3 | $744K | Sell |
20,349
-7,766
| -28% | -$284K | ﹤0.01% | 1330 |
|
|
2019
Q2 | $1.3M | Buy |
28,115
+8,926
| +47% | +$414K | 0.01% | 1068 |
|
|
2019
Q1 | $770K | Buy |
19,189
+1,228
| +7% | +$49.3K | 0.01% | 1251 |
|
|
2018
Q4 | $825K | Buy |
17,961
+411
| +2% | +$18.9K | 0.01% | 1123 |
|
|
2018
Q3 | $778K | Buy |
+17,550
| New | +$778K | 0.01% | 1245 |
|